David Degen
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology
Papers in
-
- RNA and protein synthesis mechanisms 6
- Genetics 7
- Bacterial Genetics and Biotechnology 7
- Co-authors
- Richard H. Ebright (13 shared papers)Yu Zhang (5 shared papers)Yon W. Ebright (5 shared papers)Yu Feng (5 shared papers)Sukhendu Mandal (3 shared papers)Eddy Arnold (3 shared papers)Nancy Connell (3 shared papers)Meliza Talaue (3 shared papers)
- Journals
- Organic Letters (2 papers)eLife (2 papers)The Journal of Antibiotics (1 paper)Nature Communications (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
David Degen
13 papers receiving 499 citations
Peers
Comparison fields: 5 of 56
- Molecular Medicine 60
- Infectious Diseases 136
- Pharmacology 96
- Molecular Biology 333
- Genetics 131
Countries citing papers authored by David Degen
This map shows the geographic impact of David Degen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Degen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Degen more than expected).
Fields of papers citing papers by David Degen
This network shows the impact of papers produced by David Degen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Degen. The network helps show where David Degen may publish in the future.
Co-authors
The 25 scholars most cited alongside David Degen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 126 | |
| 2 | 2017 | 107 | |
| 3 | 2014 | 62 | |
| 4 | 2014 | 59 | |
| 5 | 2014 | 38 | |
| 6 | 2019 | 32 | |
| 7 | 2012 | 22 | |
| 8 | 2015 | 19 | |
| 9 | 2014 | 16 | |
| 10 | 2017 | 14 | |
| 11 | 2022 | 6 | |
| 12 | 2023 | 2 | |
| 13 | 2024 | 1 |
About David Degen
David Degen is a scholar working on Molecular Biology, Genetics, Pharmacology, Molecular Medicine and Infectious Diseases, having authored 13 papers that have together received 504 indexed citations. Recurring topics across this work include Bacterial Genetics and Biotechnology (7 papers), RNA and protein synthesis mechanisms (6 papers), Microbial Natural Products and Biosynthesis (4 papers), Antibiotic Resistance in Bacteria (4 papers), Bacteriophages and microbial interactions (2 papers), Mycobacterium research and diagnosis (2 papers), Antimicrobial Peptides and Activities (2 papers) and Synthetic Organic Chemistry Methods (1 paper). The work is most often cited by research in Molecular Medicine (60 citations), Infectious Diseases (136 citations), Pharmacology (96 citations), Molecular Biology (333 citations) and Genetics (131 citations). David Degen has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Richard H. Ebright, Yu Zhang, Yon W. Ebright, Yu Feng, Sukhendu Mandal, Eddy Arnold, Nancy Connell, Meliza Talaue, Wei Lin and Kalyan Das. Their work appears in journals such as Organic Letters, eLife, The Journal of Antibiotics, Nature Communications and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.